These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 24136861)

  • 1. Paralogue annotation identifies novel pathogenic variants in patients with Brugada syndrome and catecholaminergic polymorphic ventricular tachycardia.
    Walsh R; Peters NS; Cook SA; Ware JS
    J Med Genet; 2014 Jan; 51(1):35-44. PubMed ID: 24136861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.
    Priori SG; Napolitano C; Memmi M; Colombi B; Drago F; Gasparini M; DeSimone L; Coltorti F; Bloise R; Keegan R; Cruz Filho FE; Vignati G; Benatar A; DeLogu A
    Circulation; 2002 Jul; 106(1):69-74. PubMed ID: 12093772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New exome data question the pathogenicity of genetic variants previously associated with catecholaminergic polymorphic ventricular tachycardia.
    Jabbari J; Jabbari R; Nielsen MW; Holst AG; Nielsen JB; Haunsø S; Tfelt-Hansen J; Svendsen JH; Olesen MS
    Circ Cardiovasc Genet; 2013 Oct; 6(5):481-9. PubMed ID: 24025405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Analysis of Arrhythmogenic Diseases in the Era of NGS: The Complexity of Clinical Decision-Making in Brugada Syndrome.
    Allegue C; Coll M; Mates J; Campuzano O; Iglesias A; Sobrino B; Brion M; Amigo J; Carracedo A; Brugada P; Brugada J; Brugada R
    PLoS One; 2015; 10(7):e0133037. PubMed ID: 26230511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sudden cardiac death in Long QT syndrome (LQTS), Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia (CPVT).
    Singh M; Morin DP; Link MS
    Prog Cardiovasc Dis; 2019; 62(3):227-234. PubMed ID: 31078562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interpreting Incidentally Identified Variants in Genes Associated With Catecholaminergic Polymorphic Ventricular Tachycardia in a Large Cohort of Clinical Whole-Exome Genetic Test Referrals.
    Landstrom AP; Dailey-Schwartz AL; Rosenfeld JA; Yang Y; McLean MJ; Miyake CY; Valdes SO; Fan Y; Allen HD; Penny DJ; Kim JJ
    Circ Arrhythm Electrophysiol; 2017 Apr; 10(4):. PubMed ID: 28404607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing.
    Bai R; Napolitano C; Bloise R; Monteforte N; Priori SG
    Circ Arrhythm Electrophysiol; 2009 Feb; 2(1):6-15. PubMed ID: 19808439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification and correlation of RYR2 missense variants in individuals with catecholaminergic polymorphic ventricular tachycardia reveals phenotypic relationships.
    Olubando D; Hopton C; Eden J; Caswell R; Lowri Thomas N; Roberts SA; Morris-Rosendahl D; Venetucci L; Newman WG
    J Hum Genet; 2020 Jun; 65(6):531-539. PubMed ID: 32152366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catecholaminergic polymorphic ventricular tachycardia in a child with Brugada pattern on ECG: one patient with two diseases?
    Janson CM; Ceresnak SR; Chung WK; Pass RH
    Heart Rhythm; 2014 Nov; 11(11):2101-4. PubMed ID: 25016147
    [No Abstract]   [Full Text] [Related]  

  • 10. Update on Genetic Basis of Brugada Syndrome: Monogenic, Polygenic or Oligogenic?
    Campuzano O; Sarquella-Brugada G; Cesar S; Arbelo E; Brugada J; Brugada R
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A balanced translocation disrupting SCN5A in a family with Brugada syndrome and sudden cardiac death.
    Yeates L; Ingles J; Gray B; Singarayar S; Sy RW; Semsarian C; Bagnall RD
    Heart Rhythm; 2019 Feb; 16(2):231-238. PubMed ID: 30170230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of genotype-phenotype correlation in Brugada Syndrome and Sudden Arrhythmic Death Syndrome families with reported pathogenic SCN1B variants.
    Gray B; Hasdemir C; Ingles J; Aiba T; Makita N; Probst V; Wilde AAM; Newbury-Ecob R; Sheppard MN; Semsarian C; Sy RW; Behr ER
    Heart Rhythm; 2018 Jul; 15(7):1051-1057. PubMed ID: 29758173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Description of a novel RyR2 mutation in a juvenile patient with symptomatic catecholaminergic polymorphic ventricular tachycardia in sleep and during exercise: a case report.
    Seidlmayer LK; Riediger F; Pagonas N; Nordbeck P; Ritter O; Sasko B
    J Med Case Rep; 2018 Oct; 12(1):298. PubMed ID: 30296944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel cardiac ryanodine receptor gene (RyR2) mutation in an athlete with aborted sudden cardiac death: a case of adult-onset catecholaminergic polymorphic ventricular tachycardia.
    Arakawa J; Hamabe A; Aiba T; Nagai T; Yoshida M; Touya T; Ishigami N; Hisadome H; Katsushika S; Tabata H; Miyamoto Y; Shimizu W
    Heart Vessels; 2015 Nov; 30(6):835-40. PubMed ID: 25092222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death.
    Nyegaard M; Overgaard MT; Søndergaard MT; Vranas M; Behr ER; Hildebrandt LL; Lund J; Hedley PL; Camm AJ; Wettrell G; Fosdal I; Christiansen M; Børglum AD
    Am J Hum Genet; 2012 Oct; 91(4):703-12. PubMed ID: 23040497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular characterization of a cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia.
    Wangüemert F; Bosch Calero C; Pérez C; Campuzano O; Beltran-Alvarez P; Scornik FS; Iglesias A; Berne P; Allegue C; Ruiz Hernandez PM; Brugada J; Pérez GJ; Brugada R
    Heart Rhythm; 2015 Jul; 12(7):1636-43. PubMed ID: 25814417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic interpretation and clinical translation of minor genes related to Brugada syndrome.
    Campuzano O; Sarquella-Brugada G; Fernandez-Falgueras A; Cesar S; Coll M; Mates J; Arbelo E; Perez-Serra A; Del Olmo B; Jordá P; Fiol V; Iglesias A; Puigmulé M; Lopez L; Pico F; Brugada J; Brugada R
    Hum Mutat; 2019 Jun; 40(6):749-764. PubMed ID: 30821013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment and Validation of a Phenotype-Enhanced Variant Classification Framework to Promote or Demote RYR2 Missense Variants of Uncertain Significance.
    Giudicessi JR; Lieve KVV; Rohatgi RK; Koca F; Tester DJ; van der Werf C; Martijn Bos J; Wilde AAM; Ackerman MJ
    Circ Genom Precis Med; 2019 May; 12(5):e002510. PubMed ID: 31112425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reappraisal of Reported Genes for Sudden Arrhythmic Death: Evidence-Based Evaluation of Gene Validity for Brugada Syndrome.
    Hosseini SM; Kim R; Udupa S; Costain G; Jobling R; Liston E; Jamal SM; Szybowska M; Morel CF; Bowdin S; Garcia J; Care M; Sturm AC; Novelli V; Ackerman MJ; Ware JS; Hershberger RE; Wilde AAM; Gollob MH;
    Circulation; 2018 Sep; 138(12):1195-1205. PubMed ID: 29959160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-Phenotype of Left Ventricular Non-Compaction Cardiomyopathy and Atypical Catecholaminergic Polymorphic Ventricular Tachycardia in Association With R169Q, a Ryanodine Receptor Type 2 Missense Mutation.
    Nozaki Y; Kato Y; Uike K; Yamamura K; Kikuchi M; Yasuda M; Ohno S; Horie M; Murayama T; Kurebayashi N; Horigome H
    Circ J; 2020 Jan; 84(2):226-234. PubMed ID: 31875585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.